Bita Moghaddam received a PhD in Biochemistry from the University of Kansas and postdoctoral training in pharmacology at Yale University. She joined the faculty of the Department of Psychiatry at Yale University in 1990 where she quickly rose to the rank of full professor. In 2003 she moved to the University of Pittsburgh where she currently is a professor of Neuroscience and Psychiatry. Her research focuses on the use of animal models to study the cellular basis of cognitive constructs that are critical to psychiatric disorders, including schizophrenia.
Dr. Moghaddam is the author of over 100 scientific papers in leading journals, including Science and Proceedings of the National Academy of Sciences. She has a longstanding track record of involvement in successful translational research. Her work has led to the discovery of the first non-monoamine targeting compound (targeting metabotropic glutamate receptors) for treatment of schizophrenia. Her research has been funded continuously since 1991, including a MERIT award from the National Institute of Mental Health.
Dr. Moghaddam has been an active educator and mentor throughout her scientific career. Her education experience has involved extensive didactic teaching of neuroscience to undergraduates, graduate students, medical students and residents. She is the recipient of many prestigious research awards, including the 2014 CINP Neuroscience Basic Research Award, the Efron award for excellence in research related to neuropsychopharmacology and the Paul Jansen Award for excellence in schizophrenia research. She has served on numerous editorial and advisory boards, as well as national and local educational and service-oriented committees.